Serum matrix metalloproteinase-7 (MMP-7) has emerged as a reproducible indicator of fibrotic progression in interstitial lung disease, with concentrations above 3.53 ng/mL associated with increased risk of progression and an adjusted odds ratio of approximately 1.26 for fibrotic worsening [35]. Here, MMP7 is linked to interstitial lung disease.